Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "Max"

321 News Found

Thermo Scientific launches Nicolet RaptIR FTIR microscope
Medical Device | February 04, 2022

Thermo Scientific launches Nicolet RaptIR FTIR microscope

New instrument helps maximize lab productivity and extends FTIR to large, heavy samples


Dr. Reddy’s impresses on sustainability and gender equality again
Sustainability | February 03, 2022

Dr. Reddy’s impresses on sustainability and gender equality again

Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row


Dr. Reddy's set to acquire Nimbus Health
News | February 03, 2022

Dr. Reddy's set to acquire Nimbus Health

The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients


Alembic receives USFDA approval for clarithromycin tablets
Drug Approval | February 01, 2022

Alembic receives USFDA approval for clarithromycin tablets

Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA


Minimizing API losses critical to responsible pharma manufacturing
News | January 27, 2022

Minimizing API losses critical to responsible pharma manufacturing

Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases


Novo Nordisk India launches world’s first and only GLP-1 RA, oral semaglutide
Drug Approval | January 20, 2022

Novo Nordisk India launches world’s first and only GLP-1 RA, oral semaglutide

Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach


Abbisko Therapeutics enters global tie-up with Lilly to develop novel molecules
Biotech | January 18, 2022

Abbisko Therapeutics enters global tie-up with Lilly to develop novel molecules

The tie-up combines Abbisko Therapeutics’ proprietary drug discovery platform with Lilly’s disease and discovery expertise


ICRA expects hospitals to report robust revenue and margin expansion in FY22
Hospitals | January 17, 2022

ICRA expects hospitals to report robust revenue and margin expansion in FY22

Occupancy is expected to be in the range of 60-62% while Average Revenue Per Occupied Bed (ARPOB) is expected to expand by least 6% in FY2022


ABL Bio collaborates with SANOFI for Parkinson’s antibody
Biotech | January 12, 2022

ABL Bio collaborates with SANOFI for Parkinson’s antibody

ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson's disease


Biotium introduces unique super-sensitive RNA Prestain Loading Dye
Biotech | January 06, 2022

Biotium introduces unique super-sensitive RNA Prestain Loading Dye

EMBER500RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels